The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
Abstract α1‐adrenoceptor antagonists are widely used for hypertension (eg, doxazosin) and benign prostatic hypertrophy (BPH, eg, tamsulosin). Some antidepressants and antipsychotics have been reported to have α1 affinity. This study examined 101 clinical drugs and laboratory compounds to build a com...
Main Authors: | Richard G. W. Proudman, Andre S. Pupo, Jillian G. Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.602 |
Similar Items
-
The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors
by: Richard G. W. Proudman, et al.
Published: (2021-08-01) -
Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
by: Meredith Mihalopoulos, et al.
Published: (2020-08-01) -
The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers
by: Mallory Batty, et al.
Published: (2016-08-01) -
Cutoff level of prostate volume to predict the efficacy of α1-D/A adrenoceptor antagonist, naftopidil
by: Yasushi Tanuma, et al.
Published: (2021-01-01) -
Chemically homogenous compounds with antagonistic properties at all α1-adrenoceptor subtypes but not β1-adrenoceptor attenuate adrenaline-induced arrhythmia in rats
by: Karolina Pytka, et al.
Published: (2016-08-01)